Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 101451-101500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04428151
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)
PHASE2Active, not recruiting
408 participants
Started: Aug 6, 2020 · Completed: Oct 15, 2025
1 condition2 sponsors120 locations
NCT04501939
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
PHASE2Active, not recruiting
5 participants
Started: Aug 6, 2020 · Completed: Jul 22, 2026
1 condition2 sponsors1 location
NCT06288334
Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
PHASE4Recruiting
80 participants
Started: Aug 6, 2020 · Completed: May 31, 2024
2 conditions1 sponsor1 location
NCT04627974
Long-term Effectiveness, Safety, and Performance of the Evoke Closed-Loop SCS System to Treat Patients With Chronic Pain of the Trunk and/or Limbs
N/AActive, not recruiting
70 participants
Started: Aug 5, 2020 · Completed: Dec 31, 2027
1 condition1 sponsor8 locations
NCT04360330
SABER Study for Selected Early Stage Breast Cancer
NARecruiting
18 participants
Started: Aug 5, 2020 · Completed: May 31, 2028
2 conditions1 sponsor1 location
NCT05501418
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19
PHASE1/PHASE2Active, not recruiting
75 participants
Started: Aug 5, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04307953
Saracatinib Trial TO Prevent FOP
PHASE2Recruiting
20 participants
Started: Aug 5, 2020 · Completed: May 6, 2025
1 condition7 sponsors3 locations
NCT04524416
MINIject Global Long-Term Follow-up Study
N/ARecruiting
300 participants
Started: Aug 5, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor9 locations
NCT04477200
Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
PHASE1Active, not recruiting
68 participants
Started: Aug 5, 2020 · Completed: Nov 5, 2027
6 conditions2 sponsors1 location
NCT04217356
Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis
N/ARecruiting
90 participants
Started: Aug 5, 2020 · Completed: Feb 5, 2026
3 conditions1 sponsor5 locations
NCT06270368
Children Born Preterm: Sustainable Health Monitoring
N/ARecruiting
650 participants
Started: Aug 5, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors4 locations
NCT04428476
Open-label Extension of the HOPE-2 Trial
PHASE2Active, not recruiting
13 participants
Started: Aug 5, 2020 · Completed: Mar 31, 2026
1 condition1 sponsor5 locations
NCT04522323
A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma
PHASE1Active, not recruiting
67 participants
Started: Aug 5, 2020 · Completed: Sep 26, 2025
1 condition1 sponsor20 locations
NCT04575935
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
PHASE3Recruiting
580 participants
Started: Aug 5, 2020 · Completed: Dec 31, 2028
25 conditions2 sponsors19 locations
NCT04534413
Ex-Vivo COF Study for Lung Cancer Observation
N/AEnrolling by invitation
50 participants
Started: Aug 5, 2020 · Completed: Dec 5, 2026
1 condition1 sponsor1 location
NCT03997266
NICU Antibiotics and Outcomes Trial
PHASE4Active, not recruiting
802 participants
Started: Aug 5, 2020 · Completed: Jun 1, 2027
6 conditions2 sponsors14 locations
NCT04103268
Neutrophil Phenotypic Profiling and Organ Injury Assessment in Patients With Sepsis
N/ARecruiting
72 participants
Started: Aug 4, 2020 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT04402086
Rheumatology Patient Registry and Biorepository
N/ARecruiting
5,000 participants
Started: Aug 4, 2020 · Completed: Jun 1, 2030
20 conditions2 sponsors1 location
NCT04219007
Vosoritide for Selected Genetic Causes of Short Stature
PHASE2Active, not recruiting
56 participants
Started: Aug 4, 2020 · Completed: Jun 1, 2035
1 condition1 sponsor1 location
NCT04090398
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones
PHASE2Active, not recruiting
70 participants
Started: Aug 4, 2020 · Completed: Jun 30, 2026
3 conditions1 sponsor30 locations
NCT04421963
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
PHASE3Enrolling by invitation
267 participants
Started: Aug 4, 2020 · Completed: Apr 6, 2027
2 conditions1 sponsor110 locations
NCT05801068
Perioperative Management of Factor Xa Inhibitors
NAActive, not recruiting
2,500 participants
Started: Aug 4, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03877666
Assessment of the Influence of Cleft Repair on Microcirculation of the Palate
N/ARecruiting
30 participants
Started: Aug 4, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04604509
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
PHASE4Recruiting
2,010 participants
Started: Aug 4, 2020 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT03953898
Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation
PHASE2Active, not recruiting
14 participants
Started: Aug 4, 2020 · Completed: Feb 20, 2026
7 conditions1 sponsor11 locations
NCT04323202
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N
PHASE1Active, not recruiting
13 participants
Started: Aug 4, 2020 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT04287166
Early Remote At-risk Diagnosis for Cerebral Palsy in Follow-up Clinics for High-risk Infants
N/AActive, not recruiting
100 participants
Started: Aug 3, 2020 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT04157127
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
PHASE1Recruiting
18 participants
Started: Aug 3, 2020 · Completed: Dec 31, 2027
3 conditions2 sponsors3 locations
NCT04996472
A Framework for Linking Sequential Pattern Rules in DLD: Perception in Adults
NARecruiting
1,260 participants
Started: Aug 3, 2020 · Completed: Jul 31, 2026
3 conditions2 sponsors2 locations
NCT04285372
Keep bIfurcation Single Stenting Simple
NAActive, not recruiting
596 participants
Started: Aug 3, 2020 · Completed: Apr 30, 2024
1 condition1 sponsor20 locations
NCT06346444
Biomarkers in Rett Syndrome
N/ARecruiting
100 participants
Started: Aug 3, 2020 · Completed: Dec 31, 2024
1 condition4 sponsors4 locations
NCT03568552
Patient Decision Aid for Opioid Use Disorder
NARecruiting
5,400 participants
Started: Aug 3, 2020 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT04439032
Artoss Prospective Spine Registry Outcomes
N/AActive, not recruiting
330 participants
Started: Aug 3, 2020 · Completed: Jun 30, 2025
1 condition1 sponsor6 locations
NCT04360395
Igniting Mobility in Adolescents and Young Adults With Cerebral Palsy
NAActive, not recruiting
120 participants
Started: Aug 3, 2020 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04353778
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
PHASE1/PHASE2Enrolling by invitation
55 participants
Started: Aug 3, 2020 · Completed: Jan 31, 2026
3 conditions2 sponsors1 location
NCT04516876
Efficacy Research of Bimanual Intensive Training in Children With Hemiplegic Cerebral Palsy
NARecruiting
30 participants
Started: Aug 3, 2020 · Completed: Aug 3, 2024
1 condition1 sponsor1 location
NCT04042259
Delayed Primary Closure Using Negative Pressure Wound Therapy
NARecruiting
350 participants
Started: Aug 3, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04501523
A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC
PHASE2Recruiting
460 participants
Started: Aug 3, 2020 · Completed: Aug 31, 2032
1 condition1 sponsor1 location
NCT04476953
COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation
PHASE2Active, not recruiting
80 participants
Started: Aug 3, 2020 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04366531
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
NARecruiting
20 participants
Started: Aug 3, 2020 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT04071769
Genentech Xenon MRI Idiopathic Pulmonary Fibrosis
PHASE2Active, not recruiting
34 participants
Started: Aug 3, 2020 · Completed: Sep 30, 2029
1 condition1 sponsor1 location
NCT04145778
Evaluation of the Muscular FORCE in the Upper Limbs of Patients Presenting a Thoracic Outlet Syndrome
N/ARecruiting
300 participants
Started: Aug 3, 2020 · Completed: Dec 3, 2024
1 condition1 sponsor1 location
NCT04509700
Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)
PHASE2Active, not recruiting
112 participants
Started: Aug 3, 2020 · Completed: Sep 30, 2027
1 condition1 sponsor105 locations
NCT04479995
Multidisciplinary Intervention In Chronic GVHD
NAActive, not recruiting
80 participants
Started: Aug 2, 2020 · Completed: Aug 1, 2024
4 conditions1 sponsor1 location
NCT03966027
Immediate Vs. Delayed Weight Bearing Postoperative Protocol in Diabetic Ankle Fractures
NARecruiting
25 participants
Started: Aug 1, 2020 · Completed: Jun 15, 2026
1 condition1 sponsor1 location
NCT03911726
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
NAActive, not recruiting
140 participants
Started: Aug 1, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04228627
Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial
PHASE4Active, not recruiting
600 participants
Started: Aug 1, 2020 · Completed: Feb 28, 2024
2 conditions4 sponsors3 locations
NCT04309461
Make Better Choices 2 for Rural Appalachians
NARecruiting
225 participants
Started: Aug 1, 2020 · Completed: Jan 30, 2026
1 condition2 sponsors1 location
NCT04115566
Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
N/ARecruiting
3,000 participants
Started: Aug 1, 2020 · Completed: Jan 1, 2030
1 condition1 sponsor1 location
NCT04921020
Assessment of Eyelid Topology and Kinetics Based on Deep Learning Method
N/ARecruiting
500 participants
Started: Aug 1, 2020 · Completed: Aug 1, 2026
1 condition1 sponsor1 location